The global leukapheresis market, valued at USD 84.58 million in 2024, continues to gain strategic relevance as advanced therapies reshape clinical practice and elevate demand for high-quality cellular starting material. With a projected CAGR of 8.8%, the market’s forward momentum reflects not only uniform global expansion but also pronounced regional disparities defined by manufacturing...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek